<DOC>
	<DOC>NCT02713113</DOC>
	<brief_summary>the investigators aimed to compare the efficacy and safety of sugammadex at doses of 1.5, 2, and 4 mg/ kg for the reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery.</brief_summary>
	<brief_title>Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery</brief_title>
	<detailed_description>Patients were randomly assigned using a randomization-computer program into three groups according to the dose of sugammadex administrated (according to the IBW after T2 of TOF): Group I: patients were given 1.5 mg / kg. Group II: patients were given 2 mg / kg. Group III: patients were given 4 mg / kg.</detailed_description>
	<criteria>morbidly obese patients of both sex (BMI &gt; 40 kg.m2) scheduled for elective laparoscopic bariatric surgery (gastric bypass or sleeve surgery) under general anesthesia using rocuronium for tracheal intubation and maintenance of NMB aged between 18 and 60 years and classified as ASA II III liver and renal dysfunction, disabling neuropsychiatric disorders, history of stroke, brain trauma in the last 12 months hypersensitivity to anesthetics, history of myocardial infarction, congestive heart failure difficult tracheal intubation, and known or suspected disorder affecting NMB.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>